The Lateral Flow Assays Market was valued at USD 10.94 billion in 2023 and is projected to reach USD 18.59 billion by 2032, growing at a CAGR of 6.09% during the forecast period 2024-2032, according to the latest report by SNS Insider. The increasing prevalence of infectious diseases, rising demand for point-of-care testing, and continuous advancements in lateral flow assay technology...